Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-05-29

Utility of tumor antigens as therapeutic and diagnostic tools

Objective

The serological profiling of anti-tumour associated antigen responses through large- scale efforts has identified over 2000 antigens. Our preliminary results show a correlation between antibody responses against a number of these with parameters indicative of indolent disease and with longer overall survival in lung cancer patients. The first aim of this project is to extend and establish these observations. Since these are antigens primarily expressed by tissues of neuroectodermal origin, we want to prove the absence of an association of antibodies against them and autoimmune paraneoplastic neuronal degeneration.

Call for proposal

FP6-2004-MOBILITY-12
See other projects for this call

Coordinator

BILKENT UNIVERSITESI
EU contribution
No data
Address
Eskisehir Yolu 8.km. Bilkent Ankara, Turkey
BILKENT, ANKARA
Türkiye

See on map

Links
Total cost
No data